The noradrenergic symptom cluster: clinical expression and neuropharmacology

References

• StahlSMStahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications3rd edCambridge, UKCambridge University Press2008
   Google Scholar
• NuttDDemyttenaereKJankaZThe other face of depression, reduced positive affect: the role of catecholamines in causation and cureJ Psychopharmacol20072146147117050654
   PubMed Web of Science ®Google Scholar
• TrivediMHHollanderENuttDBlierPClinical evidence and potential neurobiological underpinnings of unresolved symptoms of depressionJ Clin Psychiatry20086924625818363453
   PubMed Web of Science ®Google Scholar
• KurianBTGreerTLTrivediMHStrategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptomsExpert Rev Neurother2009997598419589048
   PubMed Web of Science ®Google Scholar
• ConradiHJOrmelJde JongePPresence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective studyPsychol Med2011In press.
   Google Scholar
• NierenbergAAKeefeBRLeslieVCResidual symptoms in depressed patients who respond acutely to fluoxetineJ Clin Psychiatry19996022122510221281
   PubMed Web of Science ®Google Scholar
• DremencovEEl MansariMBlierPNoradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brainBiol Psychiatry20076167167816934772
   PubMed Web of Science ®Google Scholar
• HaddjeriNde MontignyCBlierPModulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine systemBr J Pharmacol19971208658759138693
   PubMed Web of Science ®Google Scholar
• SzaboSTde MontignyCBlierPProgressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitorsInt J Neuropsychopharmacol2000311111343573
   PubMed Web of Science ®Google Scholar
• KawaharaYKawaharaHKanekoFTanakaMLong-term administration of citalopram reduces basal and stress-induced extra-cellular noradrenaline levels in rat brainPsychopharmacology (Berl)2007194738117534604
   PubMed Web of Science ®Google Scholar
• GuiardBPEl MansariMMeraliZBlierPFunctional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesionsInt J Neuropsychopharmacol20081162563918205979
   PubMed Web of Science ®Google Scholar
• MoretCCharveronMFinbergJPCouzinierJPBrileyMBiochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drugNeuropharmacology198524121112193005901
   PubMed Web of Science ®Google Scholar
• KochSHemrick-LueckeSKThompsonLKComparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in ratsNeuropharmacology20034593594414573386
   PubMed Web of Science ®Google Scholar
• MongeauRWeissMde MontignyCBlierPEffect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neuronsNeuropharmacology1998379059189776386
   PubMed Web of Science ®Google Scholar
• MoretCBrileyMEffects of milnacipran and pindolol on extracellular noradrenaline and serotonin levels in guinea pig hypothalamusJ Neurochem1997698158229231743
   PubMed Web of Science ®Google Scholar
• KitaichiYInoueTIzumiTNakagawaSKatoAKoyamaTSubchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of ratsEur J Pharmacol2005520374216153636
   PubMed Web of Science ®Google Scholar
• KitaichiYInoueTNakagawaSIzumiTKoyamaTEffect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithiumEur J Pharmacol200551621922615963494
   PubMed Web of Science ®Google Scholar
• RaiteriMDel CarmineRBertolliniALeviGEffect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamineEur J Pharmacol197741133143832672
   PubMed Web of Science ®Google Scholar
• SesackSRHawrylakVAMatusCGuidoMALeveyAIDopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporterJ Neurosci199818269727089502827
   PubMed Web of Science ®Google Scholar
• YamamotoBKNovotneySRegulation of extracellular dopamine by the norepinephrine transporterJ Neurochem1998712742809648875
   PubMed Web of Science ®Google Scholar
• DevotoPFloreGPaniLGessaGLEvidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortexMol Psychiatry2001665766411673793
   PubMed Web of Science ®Google Scholar
• LinnérLEnderszHOhmanDBengtssonFSchallingMSvenssonTHReboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortexJ Pharmacol Exp Ther200129754054611303041
   PubMed Web of Science ®Google Scholar
• BymasterFPKatnerJSNelsonDLAtomoxetine increases extra-cellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorderNeuropsychopharmacology20022769971112431845
   PubMed Web of Science ®Google Scholar
• Herrera-GuzmánIGudayol-FerréEHerrera-AbarcaJEMajor Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recoveryJ Affect Disord201012334135019896719
   PubMed Web of Science ®Google Scholar
• ItoiKSugimotoNThe brainstem noradrenergic systems in stress, anxiety and depressionJ Neuroendocrinol20102235536120210846
   PubMed Web of Science ®Google Scholar
• HainsABArnstenAFMolecular mechanisms of stress-induced prefrontal cortical impairment: implications for mental illnessLearn Mem20081555156418685145
   PubMed Web of Science ®Google Scholar
• StahlSMGradyMMMoretCBrileyMSNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressantsCNS Spectr20051073274716142213
   PubMed Web of Science ®Google Scholar
• MoojenVKMartinsMRReinkeAEffects of milnacipran in animal models of anxiety and memoryNeurochem Res20063157157716758367
   PubMed Web of Science ®Google Scholar
• SelitskiĭGVKaprinADIzvozchikovSBBolotovAVTroshinaAVMilnacipran (ixel) in the treatment of anxiodepressive and sexual disorders in patients with noninflammatory syndrome of chronic pelvic painTer Arkh2007798184
   Web of Science ®Google Scholar
• GamaCSZanattoVCPiconFLobatoMIBelmonte-de-AbreuPSEfficacy of milnacipran in treating anxiety symptoms in schizophrenic patients receiving clozapine: a case series studyRev Bras Psiquiatr20062833934017242816
   PubMed Web of Science ®Google Scholar
• MorilakDAFrazerAAntidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disordersInternational Journal of Neuropsychopharmacology2004719321815003145
   PubMed Web of Science ®Google Scholar
• SzaboSTBlierPFunctional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neuronsBrain Res200192292011730697
   PubMed Web of Science ®Google Scholar
• PariniSRenoldiGBattagliaAInvernizziRWChronic reboxetine desensitizes terminal but not somatodendritic alpha2-adrenoceptors controlling noradrenaline release in the rat dorsal hippocampusNeuropsychopharmacology2005301048105515668723
   PubMed Web of Science ®Google Scholar
• CrewsFTSmithCBPresynaptic alpha-receptor subsensitivity after long-term antidepressant treatmentScience1978202322324211589
   PubMed Web of Science ®Google Scholar
• McMillenBAWarnackWGermanDCShorePAEffects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugsEur J Pharmacol1980612392466102522
   PubMed Web of Science ®Google Scholar
• El MansariMGuiardBPChernolozOGhanbariRKatzNBlierPRelevance of norepinephrine-dopamine interactions in the treatment of major depressive disorderCNS Neurosci Ther201016e1e1720406250
   PubMed Web of Science ®Google Scholar
• ArnstenAFLiBMNeurobiology of executive functions: catecholamine influences on prefrontal cortical functionsBiol Psychiatry2005571377138415950011
   PubMed Web of Science ®Google Scholar